Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population

Head and neck squamous cell carcinoma (HNSCC) has a high prevalence and is a major cause of cancer deaths in Taiwan. However, there is still no effective salvage therapy that prolongs the life expectancy of patients with recurrent/metastatic (R/M) HNSCC. Immune checkpoint therapy that targets the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen-Chun, Chu, Pen-Yuan, Lee, Yu-Ting, Lu, Wen-Bin, Liu, Chun-Yu, Chang, Peter Mu-Hsin, Yang, Muh-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392576/
https://www.ncbi.nlm.nih.gov/pubmed/29384959
http://dx.doi.org/10.1097/MD.0000000000009519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392576/
https://www.ncbi.nlm.nih.gov/pubmed/29384959
http://dx.doi.org/10.1097/MD.0000000000009519

Ejemplares similares